Eli Lilly Bets $3.5 Billion on Pennsylvania as Pharma Giants Shift Production Stateside
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.